Showing results (41-50 of 270) with videos related to
Sort By:
Pageof 27
Transplant International : Official Journal of the European Society for Organ Transplantation|January 24, 2007
Evaluation of the efficacy and safety of a slow conversion from calcineurin inhibitor- to sirolimus-based therapies in maintenance renal-transplant patients presenting with moderate renal insufficiencyNassim Kamar, Luc Frimat, Gilles Blancho, et al.Clinical Kidney Journal|April 16, 2025
Moderately elevated ambient temperature is associated with mortality in dialysis patients, but not in transplant patientsCécile Couchoud, Thierry Lobbedez, Sahar Bayat, et al.Nephron. Clinical Practice|January 10, 2008
Evaluation and determinants of underprescription of erythropoiesis stimulating agents in pre-dialysis patients with anaemiaNathalie Thilly, Bénédicte Stengel, Stéphanie Boini, et al.Journal of Medical Case Reports|June 20, 2014
A de novo monoclonal immunoglobulin deposition disease in a kidney transplant recipient: a case reportBenjamin Savenkoff, Perrine Aubertin, Marc Ladriere, et al.American Journal of Nephrology|December 24, 2010
Outcomes of patients with delayed dialysis initiation: Results from the AVENIR studyNathalie Thilly, Stephanie Boini, Marc Soudant, et al.Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|August 19, 2008
Variability in case mix and peritoneal dialysis selection in fifty-nine French districtsCécile Couchoud, Emilie Savoye, Luc Frimat, et al.Pharmacoepidemiology and Drug Safety|August 12, 2014
Influence on quality of life from an early cinacalcet prescription for secondary hyperparathyroidism in dialysisPierre Filipozzi, Carole Ayav, Marie-Line Erpelding, et al.Medical Care|September 3, 2010
Impact of predialysis therapeutic practices on patient outcomes during the first year of dialysis: the Pharmacoepidemiologic AVENIR studyNathalie Thilly, Stéphanie Boini, Carole Loos-Ayav, et al.BMC Nephrology|November 17, 2016
Competing risk of death and end-stage renal disease in incident chronic kidney disease (stages 3 to 5): the EPIRAN community-based studyCarole Ayav, Jean-Baptiste Beuscart, Serge Briançon, et al.Nephrologie & Therapeutique|December 4, 2018
[Tubulointerstitiel nephritis and Crohn's disease, nephrotoxicity or extraintestinal manifestation of Crohn's disease? About a case]Mathilde Treffel, Jacqueline Champigneulle, Fleuria Meibody, et al.Pageof 27